| 1.61 Data as of 10:15am ET | +0.0099 / +0.62%Today’s Change | 1.20 Today|||52-Week Range 2.95 | +21.05% Year-to-Date |
The 2 analysts offering 12-month price forecasts for Cleveland BioLabs Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +117.40% increase from the last price of 1.61.

The current consensus among 2 polled investment analysts is to Buy stock in Cleveland BioLabs Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




